Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Kidney & Blood Pressure Research|September 6, 2007
The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic ratsVera Certíková Chábová, Herbert J Kramer, Ivana Vanecková, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 18, 2011
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive ratsAlexandra Sporková, Libor Kopkan, Sárka Varcabová, et al.Clinical and Experimental Pharmacology & Physiology|February 3, 2016
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic ratsZuzana Husková, Libor Kopkan, Lenka Červenková, et al.Vascular Pharmacology|July 1, 2009
Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertensionZdenka Vanourková, Herbert J Kramer, Michaela Erbanová, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 26, 2007
The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritisDirk Bokemeyer, Darius Panek, Masashi Kitahara, et al.Vascular Pharmacology|March 29, 2008
Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic ratsZdenka Vernerová, Herbert J Kramer, Angela Bäcker, et al.The Journal of Physiology|November 17, 2010
Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertensionZuzana Honetschlägerová, Zuzana Husková, Zdeňka Vaňourková, et al.Journal of Hypertension|November 4, 2006
AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertensionZdenka Vanourková, Herbert J Kramer, Zuzana Husková, et al.Life Sciences|December 31, 2013
Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic ratsVěra Čertíková Chábová, Zdenka Vernerová, Petr Kujal, et al.Kidney & Blood Pressure Research|August 3, 2004
Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic ratsPavel Dvorák, Herbert J Kramer, Angela Bäcker, et al.Pageof 6